Sechenov School
Home › Pathophysiology › Lipid Metabolism Disorders

Lipid Metabolism Disorders

Patologia *metabolismus* lipidorum

For medical students2 min readUpdated 2026-10-10

Lipid metabolism disorders encompass pathological processes affecting the digestion, transport, and intracellular transformation of fats and fat-like compounds. These disorders lead to severe clinical conditions, including obesity, wasting, and dyslipoproteinemias.

Key LipidsPhospholipids, cholesterol, triglycerides, steroids.
Membrane RoleMain component of biological cell membranes.
Levels of DisruptionDigestion, transmembrane transport, metabolism.
Clinical FormsObesity, cachexia, lipodystrophies, lipidoses.

What Are Lipids and Why Are They Needed

Lipids (lipos — fat) are a diverse group of organic molecules that include fats and fat-like compounds, such as phospholipids, cholesterol, triglycerides, and steroids.

In the body, these substances perform essential biological functions:

  1. Structural — act as the fundamental building block for all biological membranes.
  2. Regulatory — control membrane permeability and modulate the activity of membrane-bound enzymes.
  3. Signaling and communication — participate in synaptic transmission, external signal reception, and intercellular contact formation.
  4. Immunological — serve as mediators in immune and inflammatory processes.

Classification by Level of Metabolic Disruption

In pathophysiology, lipid metabolism disorders are classified based on the stage at which the disruption occurs:

Clinical Forms of Lipid Metabolism Pathology

Depending on clinical manifestations and disease course, standard forms of lipid disorders include:

Each form has distinct developmental pathways, yet all are rooted in profound defects in the utilization, transport, or storage of lipid compounds.

Mnemonic

Disorders follow the pathway of food: starting in the GI tract (digestion), moving to the intestinal wall (transport), and ending in the cell (metabolism). Clinical presentations mirror weight extremes (obesity vs. cachexia) alongside transport and structural defects (dyslipoproteinemias, lipodystrophies, lipidoses).

Frequently asked questions

How are dyslipoproteinemias classified according to Fredrickson?

The Fredrickson classification of hyperlipoproteinemias identifies 5 main types based on cholesterol and triglycerides levels, as well as lipoprotein fraction distribution:

  • Type II (Familial hypercholesterolemia): ApoB-100 gene mutation, elevated LDL, and hypercholesterolemia.
  • Type III (Familial combined hyperlipidemia): ApoE structural defect, elevated remnant chylomicrons, VLDL, IDL, and LDL, resulting in hypercholesterolemia and hypertriglyceridemia.
  • Types IV and V (Familial hypertriglyceridemia): Overproduction of VLDL, elevated VLDL and LDL, hypertriglyceridemia, and moderate hypercholesterolemia.
What types of lipidoses exist and which enzymes are deficient in them?

Lipidoses are classified by localization:

  • Intracellular — parenchymal lipidoses;
  • Adipose tissue — obesity, cachexia;
  • Arterial walls — atherosclerosis, arteriosclerosis.

Lipidoses include glycolipidoses, sphingolipidoses, gangliosidoses, mucolipidoses, leukodystrophies, lipofuscinoses, etc.

Etiologically, they are divided into:

  • Primary lipidoses — genetically determined hereditary/congenital enzymopathies;
  • Secondary lipidoses — consequences of exogenous or endogenous damaging factors.

Enzyme defects directly referenced:

  • Niemann-Pick disease (sphingomyelinosis) — decreased sphingomyelinase activity;
  • Leukodystrophies (sulfatidosis) — genetic defect of enzymes, e.g., arylsulfatase A deficiency;
  • Cholesteryl ester storage disease — lysosomal acid lipase defect.
What are the pathogenetic differences between primary and secondary obesity?
Form of ObesityPathogenetic Mechanisms
Primary (Hypothalamic)Disruption of the fat metabolism regulation system (lipostat); an independent neuroendocrine disease
Secondary (Symptomatic)Occurs as a symptom of other pathologies. Results from reduced energy expenditure and triglyceride consumption (hypothyroidism, physical inactivity) or activated lipid synthesis (diabetes mellitus, hypercortisolism)
What mechanisms underlie the development of lipodystrophies?

Lipodystrophies are hereditary or acquired lipid metabolism disorders characterized by:

  • generalized or localized loss of adipose tissue;
  • less commonly, excessive fat accumulation in subcutaneous depots.

A common pathogenetic feature is impaired normal development, distribution, or survival of adipocytes. This prevents adipose tissue from adequately storing lipids, causing ectopic fat deposition in the liver, muscles, and pancreas, leading to severe insulin resistance, hypertriglyceridemia, and hepatic steatosis.

Children may also exhibit partial subcutaneous fat loss in the face and limbs.

What are the main classes of lipids in the body?

The primary lipid representatives include phospholipids, cholesterol, triglycerides, and steroids.

What are the main causes of lipid digestion disorders?

Key causes include pancreatic lipase deficiency, impaired bile production or excretion, and disturbances in luminal or membrane digestion.

What are the clinical forms of lipid metabolism disorders?

Clinical forms include obesity, cachexia, dyslipoproteinemias, lipodystrophies, and lipidoses.

Go deeper

More topics in Pathophysiology

Etiology of Cell InjuryEtiology of InflammationThermal Balance DisordersInfectious ProcessDiabetic Ketoacidotic ComaTypical Disorders of Protein MetabolismBody Fluid Compartments: Anatomy, Distribution and DisordersHypernatremiaAcid-Base Balance IndicatorsHypovitaminosisHypoxia and HypoxemiaType II Hypersensitivity ReactionsPathophysiology →